Cancer Therapeutics Drugs Market Size

  • Report ID: 2951
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Cancer Drugs Market size was valued at USD 187.33 billion in 2024 and is likely to cross USD 744.68 billion by 2037, expanding at more than 11.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cancer drugs is estimated at USD 205.16 billion.

Extensive research associated with cancer treatment in western countries, along with the growing investment in the development of advanced therapies are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as greater exposure to risk factors like tobacco use, alcohol use, unhealthy diet and physical inactivity. According to the data collected from WHO’s International Agency for Research on Cancer, in 2021, cancer is the leading cause of deaths globally, and is responsible for about 10 million deaths per year. Globally, about 1 in 6 deaths is due to cancer.


Cancer-Therapeutics-Drugs-Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cancer drugs is estimated at USD 205.16 billion.

Cancer Drugs Market size was valued at USD 187.33 billion in 2024 and is likely to cross USD 744.68 billion by 2037, expanding at more than 11.2% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is estimated to dominate majority revenue share by 2037, owing to increasing awareness, rise in disposable incomes, high incidence rate of cancer, and need to develop innovative cancer treatment solutions in the region.

The major players in the market are F. Hoffman-La Roche Ltd, Celgene Corp, Novartis AG, Pfizer Inc, Johnson and Johnson, among others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos